These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6630614)

  • 1. Environmental UVA radiation and eye protection during PUVA therapy.
    Morison WL; Strickland PT
    J Am Acad Dermatol; 1983 Oct; 9(4):522-5. PubMed ID: 6630614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting the eye from ultraviolet A radiation during photochemotherapy.
    Deleu H; Roelandts R
    Photodermatol Photoimmunol Photomed; 1990 Dec; 7(6):233-6. PubMed ID: 2103130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of oral PUVA therapy for psoriasis. Eye protection revisions.
    J Am Acad Dermatol; 1982 May; 6(5):851-5. PubMed ID: 7096648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model of the biologically effective dose of solar UVA received by patients undergoing oral psoralen photochemotherapy for psoriasis.
    Diffey BL
    Phys Med Biol; 1981 Nov; 26(6):1129-35. PubMed ID: 7323150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular side effects of PUVA-treated patients refusing eye sun protection.
    Calzavara-Pinton PG; Carlino A; Manfredi E; Semeraro F; Zane C; De Panfilis G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():164-5. PubMed ID: 8073824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position paper--PUVA therapy. American Academy of Dermatology.
    Bickers DR
    J Am Acad Dermatol; 1983 Feb; 8(2):265-70. PubMed ID: 6402528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Environmental UV radiation levels for dosing PUVA-sol in Mexico].
    Castanedo-Cázares JP; Torres-Álvarez B; Ehnis-Pérez A; Alba-Barba I
    Rev Med Inst Mex Seguro Soc; 2013; 51(3):264-9. PubMed ID: 23883454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
    Lafond G; Roy PE; Grenier R
    Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair elicited by UVB during PUVA therapy for psoriasis.
    Bishop SC; Abel EA
    Arch Dermatol Res; 1985; 278(1):25-30. PubMed ID: 4096527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human exposure to ultraviolet radiation.
    Diffey BL
    Semin Dermatol; 1990 Mar; 9(1):2-10. PubMed ID: 2203439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoralens and ocular effects in humans.
    Glew WB; Nigra TP
    Natl Cancer Inst Monogr; 1984 Dec; 66():235-9. PubMed ID: 6531036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimising the risks of PUVA treatment.
    van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
    Speight EL; Farr PM
    Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye protection in psoralen photochemotherapy.
    Davey JB; Diffey BL; Miller JA
    Br J Dermatol; 1981 Mar; 104(3):295-300. PubMed ID: 7213563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of stand-up irradiation cubicles with UVA metal-halide lamps (and a new filter) or UVA fluorescent lamps for photochemotherapy of psoriasis.
    Calzavara-Pinton PG
    Dermatology; 1997; 195(3):243-7. PubMed ID: 9407171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical protection against long-wave ultraviolet A.
    Jarratt M; Hill M; Smiles K
    J Am Acad Dermatol; 1983 Sep; 9(3):354-60. PubMed ID: 6605370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.